Key Points
- Director Lawrence Kurzius purchased 10,000 Cooper Companies shares at an average price of $53.91, investing $539,100 and increasing his holdings by 90.1% to 21,099 shares.
- Cooper Companies reported quarterly EPS of $1.15, topping estimates of $1.12, while revenue of $1.07 billion fell short of expectations. The board also authorized a $3 billion share-repurchase program, covering up to 22.7% of outstanding shares.
- Shares opened at $53.27, near the company’s one-year low, while analysts maintained a consensus “Hold” rating with a $71.47 price target; recent guidance cuts and weaker contact-lens demand remain key concerns.
The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) Director Walter Rosebrough, Jr. purchased 3,000 shares of the business's stock in a transaction dated Monday, September 14th. The shares were purchased at an average price of $54.29 per share, for a total transaction of $162,870.00. Following the purchase, the director owned 20,000 shares of the company's stock, valued at approximately $1,085,800. This trade represents a 17.65% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.
Cooper Companies Stock Performance
COO stock opened at $53.27 on Wednesday. The Cooper Companies, Inc. has a 1-year low of $51.01 and a 1-year high of $89.83. The business has a 50-day moving average price of $70.88 and a 200 day moving average price of $69.19. The company has a market capitalization of $10.13 billion, a P/E ratio of 18.18, a PEG ratio of 2.21 and a beta of 0.82. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73.
Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.10 billion. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The firm's quarterly revenue was up .5% on a year-over-year basis. During the same period in the prior year, the business earned $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 4.53 EPS for the current fiscal year.
Cooper Companies declared that its board has initiated a share buyback plan on Wednesday, September 9th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the medical device company to purchase up to 22.7% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board believes its shares are undervalued.
Cooper Companies News Roundup
Here are the key news stories impacting Cooper Companies this week:
- Positive Sentiment: Three Cooper Companies directors reported approximately $1.33 million in combined stock purchases. Paul A. Keel bought 4,701 shares for roughly $250,000, Lawrence Kurzius purchased 10,000 shares for $539,100, and Walter M. Rosebrough Jr. acquired 10,000 shares across two transactions for approximately $541,640. The purchases may indicate that company insiders view the recent selloff as excessive. SEC insider purchase filing
- Positive Sentiment: An analysis titled “A Little More Compelling At This Price” suggests COO’s valuation has become more attractive following the decline, potentially supporting interest from value-oriented investors. Seeking Alpha analysis
- Neutral Sentiment: Rosen Law Firm announced an investigation into potential securities claims involving allegations that Cooper Companies may have issued materially misleading business information. The announcement does not establish wrongdoing, but it adds legal and headline risk for shareholders. Rosen Law Firm announcement
- Negative Sentiment: Cooper Companies reduced fiscal 2026 adjusted EPS guidance to $4.51–$4.55 from $4.58–$4.66 and cut revenue guidance to $4.23–$4.25 billion from $4.29–$4.32 billion. The revisions reflect weaker-than-expected contact-lens demand, particularly at CooperVision. Insider Monkey report
- Negative Sentiment: Reports indicated that third-quarter results included U.S. channel inventory destocking and other negative surprises, contributing to the sharp decline in COO shares. Investors are likely focused on how quickly distributors normalize inventories and whether underlying demand improves. HBSS report
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the company. Stifel Nicolaus set a $70.00 target price on Cooper Companies and gave the stock a "buy" rating in a report on Thursday, September 10th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a report on Wednesday, May 27th. Wall Street Zen lowered Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday. William Blair cut Cooper Companies from an "outperform" rating to a "market perform" rating in a research note on Thursday, September 10th. Finally, Zacks Research downgraded Cooper Companies from a "hold" rating to a "strong sell" rating in a research report on Friday, September 11th. Five analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat, Cooper Companies currently has an average rating of "Hold" and a consensus price target of $71.47.
Check Out Our Latest Report on Cooper Companies
Hedge Funds Weigh In On Cooper Companies
A number of large investors have recently made changes to their positions in the business. Sequoia Financial Advisors LLC grew its stake in Cooper Companies by 290.4% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 34,286 shares of the medical device company's stock worth $2,459,000 after buying an additional 25,504 shares during the last quarter. Tidal Investments LLC increased its position in Cooper Companies by 281.4% during the 2nd quarter. Tidal Investments LLC now owns 82,903 shares of the medical device company's stock valued at $5,945,000 after buying an additional 61,165 shares in the last quarter. National Pension Service raised its stake in Cooper Companies by 9,314.0% in the second quarter. National Pension Service now owns 526,149 shares of the medical device company's stock valued at $37,730,000 after buying an additional 520,560 shares during the last quarter. WINTON GROUP Ltd raised its stake in Cooper Companies by 379.0% in the second quarter. WINTON GROUP Ltd now owns 42,483 shares of the medical device company's stock valued at $3,046,000 after buying an additional 33,613 shares during the last quarter. Finally, Engineers Gate Manager LP boosted its holdings in Cooper Companies by 8,637.7% in the second quarter. Engineers Gate Manager LP now owns 249,897 shares of the medical device company's stock worth $17,920,000 after acquiring an additional 247,037 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.
Cooper Companies Company Profile
(
Get Free Report)
Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.
CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
